Philip Morris Current Ratio 2008-2019 | PM
Current and historical current ratio for Philip Morris (PM) from 2008 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Philip Morris current ratio for the three months ending December 31, 2019 was 1.09.
| Philip Morris Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2019-12-31 |
$20.51B |
$18.83B |
1.09 |
| 2019-09-30 |
$19.58B |
$18.05B |
1.09 |
| 2019-06-30 |
$17.16B |
$18.05B |
0.95 |
| 2019-03-31 |
$15.74B |
$18.49B |
0.85 |
| 2018-12-31 |
$19.44B |
$17.19B |
1.13 |
| 2018-09-30 |
$18.54B |
$15.60B |
1.19 |
| 2018-06-30 |
$20.03B |
$17.44B |
1.15 |
| 2018-03-31 |
$20.59B |
$17.69B |
1.16 |
| 2017-12-31 |
$21.59B |
$15.96B |
1.35 |
| 2017-09-30 |
$20.86B |
$18.51B |
1.13 |
| 2017-06-30 |
$18.43B |
$17.24B |
1.07 |
| 2017-03-31 |
$16.88B |
$13.36B |
1.26 |
| 2016-12-31 |
$17.61B |
$16.47B |
1.07 |
| 2016-09-30 |
$16.57B |
$14.26B |
1.16 |
| 2016-06-30 |
$16.05B |
$12.67B |
1.27 |
| 2016-03-31 |
$15.93B |
$14.09B |
1.13 |
| 2015-12-31 |
$15.80B |
$15.39B |
1.03 |
| 2015-09-30 |
$14.11B |
$14.10B |
1.00 |
| 2015-06-30 |
$13.77B |
$15.39B |
0.90 |
| 2015-03-31 |
$14.28B |
$14.98B |
0.95 |
| 2014-12-31 |
$15.48B |
$15.11B |
1.03 |
| 2014-09-30 |
$14.76B |
$15.12B |
0.98 |
| 2014-06-30 |
$14.71B |
$13.58B |
1.08 |
| 2014-03-31 |
$14.83B |
$13.97B |
1.06 |
| 2013-12-31 |
$16.85B |
$17.07B |
0.99 |
| 2013-09-30 |
$16.02B |
$16.02B |
1.00 |
| 2013-06-30 |
$16.76B |
$14.71B |
1.14 |
| 2013-03-31 |
$16.66B |
$14.51B |
1.15 |
| 2012-12-31 |
$16.59B |
$17.02B |
0.98 |
| 2012-09-30 |
$17.60B |
$16.73B |
1.05 |
| 2012-06-30 |
$15.56B |
$16.83B |
0.93 |
| 2012-03-31 |
$15.34B |
$15.28B |
1.00 |
| 2011-12-31 |
$14.86B |
$14.79B |
1.00 |
| 2011-09-30 |
$15.09B |
$16.05B |
0.94 |
| 2011-06-30 |
$14.33B |
$14.76B |
0.97 |
| 2011-03-31 |
$13.39B |
$14.34B |
0.93 |
| 2010-12-31 |
$13.76B |
$12.80B |
1.07 |
| 2010-09-30 |
$15.48B |
$13.71B |
1.13 |
| 2010-06-30 |
$12.92B |
$9.99B |
1.29 |
| 2010-03-31 |
$13.08B |
$9.58B |
1.37 |
| 2009-12-31 |
$14.68B |
$11.18B |
1.31 |
| 2009-09-30 |
$14.28B |
$9.84B |
1.45 |
| 2009-06-30 |
$14.73B |
$9.67B |
1.52 |
| 2009-03-31 |
$13.64B |
$8.14B |
1.68 |
| 2008-12-31 |
$14.94B |
$10.14B |
1.47 |
| 2008-09-30 |
$15.31B |
$11.40B |
1.34 |
| 2008-06-30 |
$15.75B |
$11.44B |
1.38 |
| 2008-03-31 |
$13.63B |
$7.39B |
1.84 |
| 2007-12-31 |
$14.79B |
$8.09B |
1.83 |
| 2007-09-30 |
$0.00B |
|
0.00 |
| 2007-06-30 |
$0.00B |
|
0.00 |
| 2007-03-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$110.719B |
$77.921B |
|
Philip Morris International Inc. is a leading international tobacco company. In addition to the manufacture and sale of cigarettes, including Marlboro, the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of reduced-risk products (`RRPs`). RRPs is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and industry-leading scientific substantiation, PMI aims to provide an RRP portfolio that meets a broad spectrum of adult smoker preferences and rigorous regulatory requirements.
|
